[go: up one dir, main page]

FI934194L - Kontrastmedel - Google Patents

Kontrastmedel Download PDF

Info

Publication number
FI934194L
FI934194L FI934194A FI934194A FI934194L FI 934194 L FI934194 L FI 934194L FI 934194 A FI934194 A FI 934194A FI 934194 A FI934194 A FI 934194A FI 934194 L FI934194 L FI 934194L
Authority
FI
Finland
Prior art keywords
contrast medicine
medicine
contrast
Prior art date
Application number
FI934194A
Other languages
English (en)
Other versions
FI934194A7 (fi
FI934194A0 (fi
Inventor
Torsten Almen
Arne Berg
C Allen Chang
Michael Droege
Harald Dugstad
Jere D Fellman
Sook-Hui Kim
Jo Klaveness
Scott M Rocklage
Paol Rongved
Brent Segal
Alan D Watson
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919106579A external-priority patent/GB9106579D0/en
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Priority claimed from PCT/EP1992/000698 external-priority patent/WO1992017215A1/en
Publication of FI934194A0 publication Critical patent/FI934194A0/fi
Publication of FI934194L publication Critical patent/FI934194L/fi
Publication of FI934194A7 publication Critical patent/FI934194A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C07F11/005Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/903Specified use of nanostructure for conversion, containment, or destruction of hazardous material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927Diagnostic contrast agent
    • Y10S977/928X-ray agent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927Diagnostic contrast agent
    • Y10S977/929Ultrasound contrast agent

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Liquid Crystal (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Lubricants (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI934194A 1991-03-27 1992-03-27 Varjoaineita FI934194A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919106579A GB9106579D0 (en) 1991-03-27 1991-03-27 Contrast media
GB919120507A GB9120507D0 (en) 1991-03-27 1991-09-26 Contrast media
PCT/EP1992/000698 WO1992017215A1 (en) 1990-03-28 1992-03-27 Contrast media

Publications (3)

Publication Number Publication Date
FI934194A0 FI934194A0 (fi) 1993-09-24
FI934194L true FI934194L (fi) 1993-11-23
FI934194A7 FI934194A7 (fi) 1993-11-23

Family

ID=26298647

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934194A FI934194A7 (fi) 1991-03-27 1992-03-27 Varjoaineita

Country Status (15)

Country Link
US (2) US5482699A (fi)
EP (1) EP0577675B1 (fi)
JP (1) JPH06506449A (fi)
AT (1) ATE187340T1 (fi)
AU (1) AU660013B2 (fi)
CA (1) CA2106976A1 (fi)
DE (1) DE69230400T2 (fi)
ES (1) ES2138970T3 (fi)
FI (1) FI934194A7 (fi)
HU (1) HUT65240A (fi)
IE (1) IE920996A1 (fi)
NO (1) NO933421L (fi)
NZ (1) NZ242156A (fi)
PH (1) PH29904A (fi)
SG (1) SG43930A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4188196A (en) * 1994-12-22 1996-07-10 Nissan Chemical Industries Ltd. Organobismuth derivatives and process for producing the same
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
DE19507820A1 (de) * 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
US5801228A (en) * 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US6596259B1 (en) 1998-12-22 2003-07-22 University Of Puerto Rico Metal based cubane structure contained in an octanuclear complex stable over several oxidation states and a method of producing the same
US7807137B1 (en) 1998-12-22 2010-10-05 University Of Puerto Rico Iron-based contrast agent
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
CA2581639C (en) * 2004-09-30 2016-07-26 Molecular Devices Corporation Luminescent lanthanide complexes
US7888297B2 (en) * 2005-01-06 2011-02-15 Halliburton Energy Services, Inc. Compositions for reducing the viscosity of treatment fluids
CA2596595C (en) * 2005-02-11 2014-12-16 University Health Network Compositions and methods for multimodal imaging
CN101252954A (zh) * 2005-06-30 2008-08-27 布里斯托尔-迈尔斯斯奎布药品公司 作为显像剂的酰肼偶联物
US20120148501A1 (en) * 2010-12-08 2012-06-14 Fred Geisler Radiological image enhancement with tantalum clusters
JP6032729B2 (ja) * 2012-05-08 2016-11-30 国立研究開発法人理化学研究所 イメージングマーカーおよびその利用
BR112015017818A2 (pt) * 2013-02-06 2017-07-11 Pom Patentverwaltungs Gbr heteropolioxometalatos
CN114573609B (zh) * 2022-03-07 2024-02-06 桂林理工大学 一种基于不对称双核镝配合物的单分子磁体及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE130934C (fi) *
DE263059C (fi) *
DE361960C (de) * 1920-06-01 1922-10-20 Georg Spiess Rundstapelbogenanleger
US3860611A (en) * 1972-01-19 1975-01-14 Du Pont Macrocyclic polyether polyols and condensation polymers derived therefrom
US3763188A (en) * 1972-01-19 1973-10-02 Du Pont Spiro(1,1-polyethylenedi(oxymethyl))-3-oxetanes
US3952015A (en) * 1973-11-12 1976-04-20 Carl George Krespan Macrocyclic compounds having oxa and aza linkages in the ring and containing spirooxetane groups
US4079124A (en) * 1976-04-21 1978-03-14 Medi-Physics, Inc. Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten
US4176173A (en) * 1977-07-18 1979-11-27 Medi-Physics, Inc. Radiographic compositions
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
WO1989000557A1 (en) * 1987-07-16 1989-01-26 Cockbain, Julian, Roderick, Michaelson Aminopolycarboxylic acids and derivatives thereof
FR2630547A1 (fr) * 1988-04-22 1989-10-27 Centre Nat Rech Scient Marquage froid de molecules de nature peptidique ou proteique
WO1990003190A1 (en) * 1988-09-29 1990-04-05 Ranney David F Methods and compositions for magnetic resonance imaging
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
US5213788A (en) * 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
GB9007967D0 (en) * 1990-04-09 1990-06-06 Nycomed As Compounds

Also Published As

Publication number Publication date
PH29904A (en) 1996-09-16
ATE187340T1 (de) 1999-12-15
AU1433892A (en) 1992-11-02
ES2138970T3 (es) 2000-02-01
NO933421D0 (no) 1993-09-24
FI934194A7 (fi) 1993-11-23
EP0577675B1 (en) 1999-12-08
HUT65240A (en) 1994-05-02
IE920996A1 (en) 1992-10-07
US5932190A (en) 1999-08-03
EP0577675A1 (en) 1994-01-12
US5482699A (en) 1996-01-09
FI934194A0 (fi) 1993-09-24
CA2106976A1 (en) 1992-09-28
NO933421L (no) 1993-11-24
JPH06506449A (ja) 1994-07-21
NZ242156A (en) 1994-07-26
HU9302735D0 (en) 1993-12-28
DE69230400T2 (de) 2000-08-03
AU660013B2 (en) 1995-06-08
DE69230400D1 (de) 2000-01-13
SG43930A1 (en) 1997-11-14

Similar Documents

Publication Publication Date Title
FI924297L (fi) Kontrastmedel
FI930737A7 (fi) Asialoglykoproteiiniin sidottu lääkeaine
DK0616523T3 (da) Lægemidler
FI924456L (fi) Laekemedel
DE69222622D1 (de) Spritze
FI935386L (fi) Roentgenkontrastmedel
FI943018A7 (fi) Terapeuttisia aineita
FI923379L (fi) Terapeutiska amider
NO923127L (no) Farmasoeytisk kombinasjonsformulering
NO920067D0 (no) Foradditiv for droevtyggere
DE69124516D1 (de) Katheter
FI934964L (fi) Teraupetiskt aemne
DK0515312T3 (da) Farmaceutisk præparat
FI935878L (fi) Porfycenfoereningar foer fotodynamisk terapi
FI921852L (fi) Dubbelriktat signaltransmissionssystem
FI923962L (fi) Kontrastmedel
FI925343L (fi) Tri-arginin-insuliner
DE69215919D1 (de) Medizinisches Gerät
FI934194L (fi) Kontrastmedel
DK0510687T3 (da) Infusionspræparation
FI943581A7 (fi) Ruisku
FI924744A7 (fi) Terapeuttisia aineita
DE69218727D1 (de) Medikamentenbehälter
FI934228L (fi) Tvaerbindande medel
FI943020A7 (fi) Terapeuttisia aineita